Buy Imuran
Imuran

0.85
Imuran (Azathioprine) is an immunosuppressant used to prevent organ rejection following transplants and to treat severe rheumatoid arthritis or other autoimmune disorders. It functions by reducing the activity of the body's immune system, helping to protect vital organs and reduce inflammation in chronic conditions.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Azathioprine
Reference Brand
Imuran
Manufacturer
Aspen
Product Form
Tablet, Powder for solution for injection
Regulatory Classification
Rx
Primary Category
Immunosuppressant
Product Category
Antineoplastic and immunomodulating agents, Immunosuppressants, Selective immunosuppressants
Pharmacological Class
Purine analogue, Antimetabolite
Manufacturer Description
A medicine used to suppress the immune system in auto-immune conditions or after an organ transplant.
Mechanism of Action
This medication works by reducing the activity of the body's immune system. It acts as an antimetabolite that interferes with the production of DNA and RNA, specifically slowing down the growth of certain white blood cells that would otherwise cause inflammation or attack transplanted organs.
Route of Administration
Oral
Onset Time
Several weeks
Duration
24 hours
Contraindications
Hypersensitivity to azathioprine or mercaptopurine, Pregnancy (unless benefit outweighs risk), Breastfeeding
Severe Adverse Events
Increased risk of infection, Easy bruising or bleeding, Yellowing of eyes/skin, Severe stomach pain
Common Side Effects
Nausea, Loss of appetite, Mild hair thinning
Uncommon Side Effects
Skin rash, Fever, Muscle pain, Fatigue
Drug Interactions
Allopurinol, Warfarin, ACE inhibitors, Live vaccines
Pregnancy Safety Warnings
Not recommended during pregnancy or breastfeeding unless strictly necessary.
Age Restrictions
Suitable for adults and children (weight-based dosing)
Storage Guidelines
Store at room temperature away from direct sunlight.
Related Products

Imuran FAQ

Can I travel internationally with Imuran and undergo security scans?

Imuran tablets are not considered hazardous, so they can be carried in hand luggage. Security scanners do not detect medications, but it is advisable to keep the prescription label or a copy of the prescription handy for border checks.

Does food affect how Imuran works?

Taking the pill with a meal can reduce stomach upset, but food does not significantly alter absorption. Alcohol should be limited because it may increase liver toxicity.

What does an Imuran tablet look like and how can I identify it?

Imuran tablets are typically round, film-coated, and may be scored for splitting. In the UK, the 25 mg tablet is pink, and the 50 mg tablet is white, each bearing the imprint “R-001” (manufacturer-specific). Always check the packaging for the exact imprint.

Will Imuran show up on a drug test for pilots or athletes?

Azathioprine is not listed among substances prohibited by the World Anti-Doping Agency (WADA) or aviation medical standards. However, a prescribed medication may be disclosed during a medical review, so it is advisable to inform the relevant authority.

When was azathioprine first introduced for medical use?

Azathioprine was first synthesized in the 1950s and received approval for organ-transplant immunosuppression in the early 1960s. Its use expanded to autoimmune diseases shortly thereafter.

What key clinical trial established Imuran’s efficacy in rheumatoid arthritis?

A pivotal double-blind, placebo-controlled trial published in the Annals of the Rheumatic Diseases (1995) demonstrated that azathioprine reduced joint swelling and improved functional scores in patients refractory to methotrexate.

How does Imuran compare with mycophenolate mofetil?

Both are antimetabolite immunosuppressants, but mycophenolate mofetil often has a more favorable side-effect profile regarding liver enzymes, while azathioprine is less expensive and has a long history of use. Choice depends on disease type, patient tolerance, and clinician preference.

Is it safe to store Imuran in a bathroom cabinet?

Bathrooms can experience humidity and temperature fluctuations that may degrade the tablet. Store Imuran in a cool, dry place such as a bedroom drawer or a pantry, away from moisture.

Why are generic azathioprine tablets cheaper than the brand Imuran?

Generic manufacturers produce the same active ingredient without the brand-specific marketing and packaging costs, leading to lower price points. Both contain azathioprine and are required to meet the same quality standards.

Can Imuran be used to reduce steroid dependence in ulcerative colitis?

Yes. Clinical guidelines recommend azathioprine as a steroid-sparing agent to maintain remission in ulcerative colitis, allowing patients to taper and discontinue corticosteroids under medical supervision.

What is Imuran?

Imuran is a prescription-only medication (POM) used in the United Kingdom to manage a variety of autoimmune and inflammatory conditions. The active ingredient in Imuran is azathioprine, an immunosuppressant that belongs to the class of thiopurine drugs. Imuran is supplied as a pill in two strengths-25 mg and 50 mg-and is marketed in the UK by Roche under the brand name Imuran. It is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA) and requires a prescription from a qualified healthcare professional.

How Imuran Works in the Body

Azathioprine is a pro-drug that is converted in the body to 6-mercaptopurine (6-MP) and then to active metabolites that inhibit the synthesis of purine nucleotides. By blocking purine production, azathioprine interferes with the proliferation of rapidly dividing cells, particularly T-lymphocytes and B-lymphocytes. This reduction in immune cell activity dampens the autoimmune response that drives conditions such as rheumatoid arthritis and inflammatory bowel disease.

  • Onset of action: therapeutic effects typically appear after 2-4 weeks of consistent dosing, with full immunosuppressive activity achieved over several months.
  • Duration: the drug remains active as long as it is taken; its metabolites are cleared within a few days after discontinuation, but immune modulation may persist for a short period.
  • Metabolism: the conversion to 6-MP is mediated by the enzyme thiopurine methyltransferase (TPMT). Patients with low TPMT activity are at increased risk of toxicity.

Conditions Treated by Imuran

Imuran is approved by the MHRA for the following indications:

  • Rheumatoid arthritis (as a disease-modifying antirheumatic drug)
  • Ulcerative colitis and Crohn’s disease when conventional therapies are insufficient
  • Systemic lupus erythematosus (as an adjunct to other agents)
  • Autoimmune hepatitis (to maintain remission)
  • Organ transplantation (as part of combination immunosuppressive regimens to prevent rejection)

These approvals apply to adult patients and, in some cases, to children when the benefit-risk balance is considered appropriate by the treating specialist.

Evidence-Based Off-Label Uses

Research and clinical guidelines have explored several off-label applications for azathioprine. While not formally approved by the MHRA, the following uses have supporting evidence:

  • IgA nephropathy - small-scale trials suggest a reduction in proteinuria.
  • Autoimmune uveitis - case series report disease control when steroids are tapered.
  • Multiple sclerosis - limited data from early studies indicate potential benefit as a steroid-sparing agent.

Disclaimer: Off-label use requires careful medical supervision, individualized risk assessment, and may involve additional monitoring.

Evaluating Imuran for Your Health Profile

Who Should Consider Imuran?

  • Adults with moderate to severe autoimmune disease who have not responded adequately to first-line therapies.
  • Patients requiring long-term immunosuppression where steroid use is undesirable.

Absolute Contraindications

  • Known hypersensitivity to azathioprine or any of its components.
  • Pregnant women (category D) - azathioprine crosses the placenta and may cause fetal harm.
  • Breastfeeding mothers - drug excreted in milk; risks to the infant outweigh benefits.
  • Patients with severe bone-marrow failure (e.g., aplastic anemia).
  • Documented TPMT deficiency (very low enzyme activity).

Relative Contraindications & Special Populations

  • Live vaccines - should be avoided while on azathioprine.
  • Elderly - increased susceptibility to infection and myelosuppression; dose adjustments may be needed.
  • Renal or hepatic impairment - careful dose titration and more frequent monitoring.
  • Pediatric patients - dosing is weight-based; TPMT testing is essential before initiation.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Nausea or loss of appetite (commonly reported).
  • Mild fatigue or headache.
  • Transient abdominal discomfort.
  • Mild increase in liver enzymes (often detected on routine labs).

Serious Adverse Events

  • Myelosuppression - leukopenia, anemia, or thrombocytopenia, which can be life-threatening.
  • Hepatotoxicity - marked elevation of transaminases or cholestasis.
  • Pancreatitis - severe abdominal pain with elevated enzymes.
  • Infection risk - opportunistic infections such as pneumonia or reactivation of latent viruses.
  • Malignancy - a small but recognized increase in lymphoma and skin cancer risk with long-term use.

Drug Interactions

  • Allopurinol - co-administration markedly heightens bone-marrow toxicity; dose of azathioprine should be reduced to ≤25 % of the usual amount.
  • Warfarin - azathioprine may potentiate anticoagulant effects; monitor INR closely.
  • Other immunosuppressants (e.g., tacrolimus, cyclosporine) - additive immunosuppression may increase infection risk; dose adjustments often required.
  • Live vaccines - effectiveness reduced and risk of vaccine-derived infection increased; avoid while immunosuppressed.

Food and Lifestyle Interactions

  • Alcohol - can worsen liver toxicity; limit intake.
  • Sun exposure - photosensitivity is uncommon but patients should use sunscreen if they develop skin reactions.
  • Driving or machinery - azathioprine does not typically impair cognition; however, severe fatigue or infection-related dizziness should be reported to a clinician.

How to Take Imuran

  • Starting dose: typically 1-3 mg/kg per day, divided into two doses, based on body weight and TPMT activity.
  • Maintenance: many patients stabilize on 1-2 mg/kg per day; the maximum recommended dose is 3 mg/kg per day.
  • Tablet strengths: 25 mg and 50 mg tablets are taken whole; they may be swallowed with food to lessen gastrointestinal upset.
  • Missed dose: take the missed tablet as soon as remembered unless the next scheduled dose is within a few hours; do not double the dose.
  • Overdose: symptoms may include nausea, vomiting, severe fatigue, and signs of bone-marrow suppression. Seek emergency medical attention; treatment is mainly supportive, with possible use of filgrastim for neutropenia.
  • Discontinuation: abrupt cessation can provoke disease flare; a gradual taper is usually recommended under medical supervision.

Monitoring and Follow-Up

  • Complete blood count (CBC): weekly for the first 2 weeks, then monthly; more frequent checks if abnormal values appear.
  • Liver function tests (LFTs): baseline, then monthly for the first 3 months, then quarterly.
  • Renal function: assess serum creatinine and eGFR at baseline and periodically.
  • TPMT activity: measured before the first dose; patients with intermediate activity may require a reduced starting dose, while those with severe deficiency should avoid azathioprine.
  • Infection surveillance: patients should report fevers, sore throats, or unusual bruising promptly.

Storage and Handling

  • Keep tablets in the original container, tightly closed, and store below 30 °C away from moisture and direct sunlight.
  • Do not refrigerate.
  • Keep out of reach of children and pets.
  • Dispose of unused tablets according to local pharmacy take-back programs or follow the disposal instructions on the package label.

Medication-Specific Glossary

Thiopurine Methyltransferase (TPMT)
An enzyme that metabolises azathioprine; low activity increases risk of bone-marrow toxicity, so testing is performed before treatment.
Purine Synthesis Inhibition
The process by which azathioprine blocks the formation of purine nucleotides, limiting DNA/RNA synthesis in rapidly dividing immune cells.
Myelosuppression
A reduction in bone-marrow activity leading to decreased blood cell production, manifested as leukopenia, anemia, or thrombocytopenia.
Hepatotoxicity
Liver injury caused by a drug, indicated by elevated liver enzymes or clinical signs of liver dysfunction.
Immunosuppression
The deliberate dampening of the immune response to prevent harmful inflammation or rejection of transplanted organs.

Medical Disclaimer

This article provides educational information about Imuran and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Imuran is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Our Projects: Directory for DMARD Medication - Hydroxychloroquine Price